This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Riboscience LLC. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Ronald Hawley: Innovator in Pharmaceutical Chemistry
Introduction
Ronald Hawley is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymatic activities.
Latest Patents
Hawley's most recent patent is titled "Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors." This patent describes certain bicyclic heteroaryl compounds that inhibit ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) enzymatic activity. These compounds are useful for treating diseases and conditions that are modulated, at least in part, by ENPP1. The patent also includes pharmaceutical compositions containing these compounds and outlines processes for their preparation.
Career Highlights
Hawley is currently associated with Riboscience LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic agents that can effectively target and modulate biological pathways.
Collaborations
One of his notable collaborators is Klaus G Klumpp, with whom he has worked on various projects aimed at advancing pharmaceutical research.
Conclusion
Ronald Hawley's contributions to the field of pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in developing new therapeutic solutions.